Slug (Snail2) plays critical roles in regulating the epithelial-mesenchymal transition (EMT) programs operative during development and disease. However, the means by which Slug activity is controlled remain unclear. Herein we identify an unrecognized canonical Wnt/ GSK3β/β-Trcp1 axis that controls Slug activity. In the absence of Wnt signaling, Slug is phosphorylated by GSK3β and subsequently undergoes β-Trcp1-dependent ubiquitination and proteosomal degradation. Alternatively, in the presence of canonical Wnt ligands, GSK3β kinase activity is inhibited, nuclear Slug levels increase, and EMT programs are initiated. Consistent with recent studies describing correlative associations in basal-like breast cancers between Wnt signaling, increased Slug levels, and reduced expression of the tumor suppressor Breast Cancer 1, Early Onset (BRCA1), further studies demonstrate that Slug-as well as Snail-directly represses BRCA1 expression by recruiting the chromatin-demethylase, LSD1, and binding to a series of E-boxes located within the BRCA1 promoter. Consonant with these findings, nuclear Slug and Snail expression are increased in association with BRCA1 repression in a cohort of triple-negative breast cancer patients. Together, these findings establish unique functional links between canonical Wnt signaling, Slug expression, EMT, and BRCA1 regulation.
S lug (also termed Snail2) is a C 2 H 2 zinc-finger transcriptional repressor belonging to the three-member family of Snail proteins (Snail, Slug, and Smuc) (1, 2) . First recognized for its participation in events associated with the epithelial-mesenchymal transition (EMT) programs that characterize early development, more recent studies have identified postnatal roles for Slug in a wide variety of carcinomatous states (1) (2) (3) (4) (5) (6) (7) . To date, Slug expression has been linked to cancer stem cell formation, cell cycle regulation and apoptosis as well as invasion and metastasis (1) (2) (3) (4) (5) (6) (7) . However, the Slug protein, like that of Snail, is rapidly turned over by the ubiquitin-proteasome system in vivo, and the key factors responsible for regulating Slug protein stability and activity remain largely undefined (2, 8) . Interestingly, recent studies have identified a subset of breast cancer patients (the so-called basal-like breast carcinoma phenotype) whose lesions display an EMT-like signature associated with increased Wnt signaling, upregulated Slug expression, and epigenetic silencing of the tumor suppressor BRCA1 (7, (9) (10) (11) (12) (13) . Despite these associations, however, no molecular pathways have been established that functionally link these potentially disparate phenotypes together.
Herein we demonstrate that Slug protein stability and activity are controlled by a heretofore undescribed GSK3β-dependent phosphorylation process that primes phospho-Slug for ubiquitination by the E3 ligase β-Trcp1 and its subsequent proteasomal degradation. In the presence of canonical Wnt agonists, however, GSK3β activity is suppressed and Slug phosphorylation is blocked, thereby allowing Slug protein levels and activity to increase. Further, in response to Wnt signaling, stabilized Slug is not only capable of driving cancer cell EMT programs and tissueinvasive activity, but also serves to repress BRCA1 expression by binding to the BRCA1 promoter and recruiting the histone demethylase LSD1. Together, these studies identify a unique Wnt/GSK3β/Slug axis that controls cancer cell EMT programs while coordinately regulating BRCA1 expression.
Results
Slug, a GSK3β Substrate. Consistent with the rapid turnover of Slug protein in a model Xenopus system (8) , the t ½ of epitopetagged Slug is ∼0.5 h in transfected MCF-7 breast carcinoma cells, and the protein only accumulates to detectable levels in the presence of the proteasome inhibitor MG132 (Fig. 1A and Fig.  S1 ). Given the short half-life of Slug, the protein sequence of Slug and the similarly short-lived Snail protein were aligned to identify conserved domains that might similarly affect Slug stability (8, (14) (15) (16) (17) . Interestingly, Slug contains a previously unrecognized GSK3β phosphorylation motif similar to that found in Snail (Fig. 1B) (14) (15) (16) (17) . As such, either recombinant Slug or Snail was expressed in Escherichia coli and the recombinant protein incubated with GSK3β in the presence of [γ-32 P]ATP. As shown in Fig. 1C , Slug, like Snail, is phosphorylated by GSK3β in a dose-dependent fashion. To further refine the search for phosphorylated residues, four nonoverlapping Slug fragments (aa 1-62, 63-130, 131-200, and 201-286) were generated and incubated with GSK3β and [γ- 32 P]ATP. Only the domain encompassing amino acid residues 63-130, wherein the putative GSK3β recognition motif is embedded, serves as a specific substrate for phosphorylation (Fig. 1D ; the nonspecific band that appears in the incubation mixture with the aa 1-62 fragment does not colocalize with the Coomassie-stained peptide). Because at least two potential GSK3β consensus motifs can be located within the 63-130 fragment (Fig. 1B) (18) , each of the serine residues was mutated to an alanine residue within the context of full-length Slug, and GSK3β-dependent phosphorylation was reassessed. Compared with the level of phosphorylation observed in wildtype Slug (Slug-WT), the phosphorylation of the Slug S92/S96/ S100/S104 → A92/A96/A100/A104 mutant (Slug-4A) is almost completely abolished, whereas the phosphorylation status of the S77/S81 → A77/A81 mutant is unaffected (Fig. 1D) . Consistent with these results, (i) following incubation of recombinant Slug with recombinant GSK3β and ATP, mass spectroscopy identifies phosphorylated residues at amino acid residues Ser-96, 100, and 104 (Fig. 1E); (ii) the half-life of Slug-4A increases 10-fold relative to Slug-WT to 5.0 h; and (iii) Slug-4A levels remain stable in the transfected cells either in the absence or presence of MG132 (Fig. 1A and Fig. S1 ). Whereas a homologous serine-rich domain found in Snail regulates its nuclear localization as a function of its ability to mask a nuclear export signal embedded in proximity to its zinc-finger domain, Slug does not contain a similar nuclear export motif (19) . Consequently, Slug nuclear localization is unaffected by the 4A mutation (Fig. S1 ).
GSK3β-β-Trcp1-Dependent Phosphorylation/Ubiquitination Axis Regulates Slug Protein Levels. To confirm GSK3β-Slug interactions in vivo, 293T cells were cotransfected with either FLAG-tagged Slug-WT or the Slug-4A mutant in combination with HA-tagged GSK3β in the presence of MG132. Following immunoprecipitation of GSK3β with an anti-HA antibody and immunoblotting with anti-FLAG, GSK3β is found in association with both wild-type and mutant Slug (Fig. S2) . In reciprocal fashion, Slug-GSK3β binding is confirmed following immunoprecipitation of wild-type or mutant Slug with anti-FLAG antibody and immunoblotting with anti-HA (Fig. S2) . The binding interactions detected between Slug and GSK3β in vivo are likely direct; bacterially expressed GST fusion proteins of Slug-WT or Slug-4A bind HA-tagged GSK3β that had been translated in a rabbit reticulocyte lysate system (Fig. S2) .
Following GSK3β-dependent phosphorylation, multiple substrates are consequently destined for degradation via the ubiquitinproteasome pathway (18) . As such, Slug-WT was expressed in 293T cells in the absence or presence of the synthetic GSK3 inhibitors SB216763, CHIR99021, or BIO (20) and with or without MG132. Although exogenous Slug protein is only marginally detectable in transfected 293T cells, Slug protein levels are increased dramatically in cells treated with GSK3 inhibitors alone, MG132 alone, or GSK3 inhibitors and MG132 in combination (Fig. S2) . Likewise, when either GSK3 or proteasome activity is inhibited in MDA-MB-231 breast carcinoma cells or SK-MEL-5 melanoma cells, endogenous Slug protein levels increase without affecting Slug mRNA levels (Fig. S2 ). Although either GSK3β or GSK3α could potentially phosphorylate the serine-rich Slug motif (18, 20) , specific silencing of GSK3β alone suggests that this isoform plays the major role in regulating Slug levels (Fig. S2) . Whereas either GSK3 isoform may phosphorylate Slug in a cell context-specific fashion, the half-life of the nonphosphorylatable Slug-4A mutant is equally stable in the absence or presence of GSK3 inhibitors or proteasome inhibitors (Fig. 1A and Fig. S2 ).
Previous reports have demonstrated that GSK3β-phosphorylated substrates are ubiquitinated by E3 ubiquitin ligase family members such as FBXW7, FBX4, or β-Trcp1 (18, 21) . Preliminary studies revealed that overexpression of either FBXW7 or FBX4 did not affect Slug protein stability, but given the structure/ function similarities between Slug and Snail, and the dominant role played by β-Trcp1 as the ligase responsible for Snail ubiquitination (14) (15) (16) (17) , potential interactions between Slug and β-Trcp1 were alternately assessed-despite the fact that Slug (unlike Snail) does not contain a classic, β-Trcp1 recognition site (i.e., DSGXXS) (21) . To this end, MCF-7 cells were cotransfected with mock or myc-tagged β-Trcp1 in combination with either FLAG-tagged Slug-WT or Slug-4A, and the cell lysates were subjected to ubiquitination analysis. Following Slug immunoprecipitation, β-Trcp1 is only found in association with Slug-WT and not the unphosphorylatable Slug-4A mutant (Fig. S3) . Furthermore, Slug-WT is heavily ubiquitinated relative to Slug-4A (Fig. S3) . Consistent with these findings, β-Trcp1 silencing increases the steady-state levels of Slug-WT, but not Slug-4A (Fig.  S3) . Conversely, β-Trcp1 overexpression lowers Slug-WT levels without affecting Slug-4A levels (Fig. S3) . Together, these data are consistent with a model wherein β-Trcp1 recognizes GSK3β-phosphorylated Slug and catalyzes its ubiquitination.
Recent studies have demonstrated that Xenopus Partner of paired, as well as its mammalian homolog, FBXL14, can also support Slug ubiquitination via a pathway that operates independently of GSK3β-dependent phosphorylation (8, 22) . As such, MCF-7 cells (which express endogenous FBXL14) were cotransfected with an FBXL14 shRNA (or alternatively, a scrambled control) and either Slug-WT or Slug-4A (Fig. S3) . Under these conditions, FBXL14 silencing increases the steadystate protein levels of both wild-type and mutant Slug without affecting Slug mRNA levels (Fig. S3) . Hence, the regulation of Slug protein levels falls under the dual regulation of GSK3β-dependent and independent ubiquitination pathways that are mediated, respectively, by β-Trcp1 and FBXL14 (Fig. S3 ).
Wnt-GSK3β Signaling Pathway Regulates Slug-Dependent EMT. Canonical Wnt signaling pathways activate Snail-dependent EMT programs by increasing Snail protein levels as a consequence of preventing its GSK3β-dependent phosphorylation and subsequent ubiquitination and proteasomal degradation (15) (16) (17) . To determine whether Wnt signaling similarly affects Slug-dependent EMT programs, MCF-7 cells were transfected with Slug-WT or Slug-4A expression vectors and incubated with Wnt3a. Under these conditions, Slug-WT protein levels are markedly increased in tandem with endogenous β-catenin levels and decreased nuclear GSK3β activity (without altering Slug mRNA expression) (Fig. 2A) . By contrast, Wnt3a does not affect the stability of Slug-4A (Fig. 2A) . Complementing these results, MCF-7 cells engineered to stably express Slug-WT only marginally increase Slug protein levels without affecting (i) E-cadherin or vimentin protein levels or (ii) mRNA levels for CDH1, OCLN, VIM, or FN (Fig. 2B) . In stable lines expressing the nonphosphorylatable Slug-4A mutant, however, markedly higher Slug protein levels are detected, whereas E-cadherin protein expression is repressed and vimentin protein levels are increased (Fig. 2 B and C). In tandem with these results, Slug-4A up-regulates VIM and FN mRNA levels and decreases CDH1 and OCLN mRNA expression (Fig. 2B ). As expected, Slug-4A is also a more powerful repressor of E-cadherin reporter activity than Slug-WT, consistent with the greater stability of the mutant protein (Fig.  2D) . Finally, when the ability of stable MCF-7 transfectants expressing Slug-WT versus Slug-4A to drive basement membrane invasion-the sine qua non of EMT programs (1, 2)-is assessed in a chick chorioallantoic membrane assay (CAM) (23), the stabilized Slug mutant triggers an approximately fourfold increase in invasion relative to Slug-WT (Fig. 2E ).
Unexpected Link Between Snail/Slug-Induced EMT and BRCA1
Repression. In searching for signaling pathways that might affect Slug protein stability or function, the tumor suppressor BRCA1 has recently been reported to stabilize Slug protein levels in mammary epithelial cells (11) . However, as opposed to results obtained in nontransformed mammary epithelial cells (11) , when endogenous BRCA1 expression is silenced in either Slug-WT-transfected MCF-7 or MDA-MB-231 breast carcinoma cells, significant changes in Slug protein levels are not detected (Fig. S4) . Interestingly, however, the BRCA1 promoter contains multiple Snail family-responsive E-boxes (see below) (1, 2), raising the possibility that the GSK3β-Slug as well as the GSK3β-Snail axis may serve as upstream regulators of BRCA1 expression. Indeed, when the levels of either endogenous Slug or Snail are increased by treating MDA-MB-231 breast carcinoma cells with the GSK3 inhibitors BIO or CHIR99021, or alternatively Wnt3a, both Slug and Snail protein levels increase [in tandem with levels of the alternate GSK3β target, β-catenin (18)], whereas BRCA1 mRNA and protein levels are suppressed (Fig. 3 A and B). Conversely, when either endogenous Slug or Snail expression is silenced in MDA-MB-231 cells, BRCA1 mRNA and protein levels increase in tandem with BRCA1 promoter activity ( (Fig. 3D ). To determine whether Slug or Snail represses BRCA1 expression by binding to the BRCA1 promoter E-boxes, Slug-or Snailtransfected MCF-7 cells were fixed, genomic DNA-sheared, and subjected to ChIP analysis. As expected, a DNA fragment containing the three E-boxes found in the E-cadherin promoter can be amplified from the genomic DNA immunoprecipitated from either wild-type Slug or Snail stable transfectants as well as from transfectants expressing the nonphosphorylatable Slug or Snail mutants (Fig. S4) . Likewise, three fragments targeting the three consensus E-boxes located within the BRCA1 promoter [i.e., CANNTG (1)] are amplified from the immunoprecipitated genomic DNA isolated from either the Slug or Snail wild-type and mutant transfectants ( Fig. 3E and Fig. S4 ). The ability of Slug or Snail promoter binding interactions to repress BRCA1 reporter activity is further confirmed in (i) MCF-7 cells cotransfected with the full-length BRCA1 promoter (i.e., from bp −1582 to +36) and either wild-type or mutant Slug or Snail (Fig. 3F ) and (ii) transfected MDA-MB-231 cells wherein BRCA1 reporter activity and protein levels are derepressed following either the silencing of Slug or Snail alone or in combination (Fig. 3G ). Mutational analysis of the BRCA1 promoter demonstrates that each of three E-boxes located within this fragment support Slug or Snail repressive activity, with the third E-box (from −256 to −251) displaying the strongest activity (Fig. 3H) .
Snail/Slug-LSD1 Axis Regulates BRCA1 Expression. The ability of Snail family members to repress transcriptional activity of target genes has been linked to the recruitment of histone modifying cofactors (1, 2, (24) (25) (26) . To determine whether the de-repression of BRCA1 expression observed following Slug or Snail silencing is linked to histone modifications within its promoter region, ChIP analyses were performed in Slug-or Snail-silenced MDA-MB-231 cells using antibodies that recognize di-or trimethylated H3K4 (H3K4me2 or H3K4me3) or acetylated H3K9 (H3K9Ac), histone marks associated with increased transcriptional activity (1, 2, (24) (25) (26) . As shown in Fig. 4A , the level of H3K4me2, but not of H3K4me3 or H3K9Ac, is increased at the BRCA1 promoter following Slug or Snail silencing. Conversely, when MCF-7 cells are transfected with stable Slug-4A or Snail-96A mutants, the level of H3K4me2 is decreased at the BRCA1 as well as E-cadherin promoters (Fig. 4B) .
In considering potential mechanisms by which Slug or Snail modifies H3K4 methylation status, Snail can associate with the histone demethylase LSD1 (25, 26) . Indeed, when LSD1 expression is silenced, both BRCA1 and E-cadherin promoter activities are increased (Fig. 4C) . LSD1 can be found in complex with either epitope-tagged Snail or Slug as well as previously described components of the Mi-2/nucleosome remodeling and deacetylase complex, HDAC1 and Mi-2β (Fig. 4D) (27) . Although the bulk of repressive activity exerted by Snail or Slug on BRCA1 expression could be linked to LSD1, targeting both LSD1 and Snail or Slug exerts even stronger effects on BRCA1 promoter activity (Fig. 4E) . Taken together, Wnt/GSK3β-dependent regulation of Slug as well as Snail activities integrates the control of BRCA1 expression within the confines of a general EMT program.
Slug/Snail-BRCA1 Axis in Triple-Negative Breast Cancer. Given previously described associations between basal-like breast cancers and reduced BRCA1 expression (12, 13) (Fig. S5) . Hence, the majority of triple-negative breast cancer patients expressing low levels of BRCA1 coexpress either nuclear Snail or Slug.
Discussion
In breast cancer, Snail activity falls under the regulation of a Wnt/GSK3 signaling cascade (1, 2, 15, 16 ). However, given sequence divergence between Slug and Snail, it has been assumed that distinct mechanisms of regulation have evolved to specifically control Slug posttranscriptional activity (8 (2, 17) .
Following its GSK3β-dependent phosphorylation, Slug is ubiquitinated by β-Trcp1, despite the absence of a classic destruction box sequence (21) . In this regard, an increasing number of GSK3β targets have been identified that contain noncanonical, β-Trcp1 recognition motifs (21) . Acidic phosphomimetic residues (D/E) can function as alternate pS/T sites within destruction boxlike motifs, raising the possibility that a 103 EpSPTSD 109 sequence found in Slug serves as the β-Trcp1 target (underline indicates critical residues), and further studies are underway to address this issue (21, 28) . Nevertheless, Slug ubiquitination is not solely controlled by its GSK3β-dependent phosphorylation; Slug can also be targeted by the ubiquitin ligase FBXL14 (8, 22) .
Despite interest in the association between canonical Wnt signaling and the induction of Slug-dependent EMT-like programs in basal-like breast cancers (9-11, 29, 30) , the molecular mechanisms underlying the documented association between this cancer subtype and the down-regulated expression of the tumor suppressor BRCA1 have not been defined previously (12, 31) . Women carrying germ line mutations in BRCA1 can develop aggressive basal-like breast cancers wherein dysregulated Slug expression has been proposed to alter mammary progenitor cell fate (11) . Interestingly, however, sporadic breast cancers, particularly those falling within the basal-like subtype, display decreased BRCA1 expression in the absence of genetic mutation (12, 31, 32) . In considering potential mechanisms by which Snail family members repress BRCA1 expression, three lines of evidence were considered. First hypoxia, an established inducer of Snail and Slug expression (9, 33) , has been recently shown to trigger the epigenetic regulation and silencing of the BRCA1 promoter via LSD1-mediated decreases in H3K4 methylation (31) . Second, LSD1 is up-regulated in estrogen-negative breast cancers, a phenotype commonly observed in the basal-like carcinomas (34) . Third, Snail family members have been shown to recruit a growing number of histone modifiers, including LSD1, to exert epigenetic control over targeted genes (25, 26) . Whereas LSD1 binds to the Snail SNAG domain (25, 26) , this motif is highly conserved in Slug as well (35) . Indeed, Slug as well as Snail binds LSD1 and represses BRCA1 expression by recruiting the H3K4 demethylase to the targeted promoter. Interestingly, whereas Slug, like Snail, can induce Zeb1 and Zeb2 expression (30) , neither of the ZEB family members plays significant roles in Slug-or Snail-mediated BRCA1 repression (Fig. S6) .
In sampling a cohort of breast cancer tissues, Slug and/or Snail expression was, as described recently (36) , almost entirely confined to triple-negative tissues. Among the BRCA1 low subpopulation, 24 of 37 patients expressed Slug or Snail, supporting the contention that the Snail/Slug/BRCA1 axis is operative in vivo. Of these 24 patients, 10 samples were positive for Slug and Snail in tandem or Slug alone ( Table 1) . The other 14 patients in this subset expressed Snail alone, but we cannot rule out differences in the sensitivity between the anti-Snail and anti-Slug antibodies. The functional impact of Snail/Slug-dependent BRCA1 repression remains to be determined, but BRCA1 plays important roles in controlling DNA repair, cell cycle checkpoint regulation, transcription, progenitor cell fate determination, and even cell motility (37, 38) . Because many of these BRCA1-regulated responses likewise fall under the purview of Snail/Slug expression (1, 2), coupled with the fact that Snail-dependent repression may extend to the structurally distinct BRCA2 gene (39), we posit that normal and neoplastic cell functions are integrated through reciprocating interactions that operate between these two networks. Indeed, preliminary studies indicate that both Slug and Snail can induce EMT programs associated with Zeb1/2, vimentin, and fibronectin expression while repressing BRCA1 as well as BRCA2 in tandem with sensitizing mammary epithelial cells to etoposide-mediated DNA damage (Fig. S7 ). This effect, coupled with the known anti- Lysates from MDA-MB-231 cells stably expressing Scr-, Slug-, or Snail-shRNA were subjected to ChIP analysis using antibodies directed against H3K4me2, H3K4me3, or H3K9Ac and BRCA1 occupancy was determined by qPCR. **P < 0.01. (B) Cell lysates from MCF7 cells stably expressing mock, Snail-96A, or Slug-4A expression vectors were subjected to ChIP analysis using anti-H3K4me2 antibody and BRCA1 or E-cadherin occupancy was determined by qPCR. **P < 0.01. (C) MDA-MB-231 cells stably expressing Scr-shRNA, LSD1-shRNA-1 or LSD1-shRNA-2 were cotransfected with either a BRCA1 or E-cadherin promoter construct, and the cell lysates were subjected to luciferase assays. Inset, LSD1 protein levels in the indicated cell lysates. **P < 0.01. (D) 293T cells were cotransfected with mock, FLAG-tagged Snail, or Slug expression vectors, and whole cell extracts prepared, subjected to anti-FLAG immunoprecipitation, and analyzed by Western blot with the indicated antibodies.
(E) MDA-MB-231 cells stably expressing Scr-shRNA or LSD1-shRNA-1 were transduced with lentiviruses expressing Scr-shRNA, Slug-shRNA, or SnailshRNA. The cells were transfected with a BRCA1 promoter construct, and the cell lysates were subjected to luciferase assay (Left) and Western blotting analysis (Right). **P < 0.01, treated vs. control. apoptotic activities of Slug and Snail (1, 2) , raises the interesting possibility that these transcription factors may promote chromosome instability in neoplastic states. The ability of canonical Wnt signaling to coregulate Slug and Snail is consistent with recent studies documenting dual roles for these transcriptional repressors in events ranging from TGFβ signaling to vitamin D receptor expression and metastasis (1, 2) . Nevertheless, Slug and Snail protein levels are not necessarily coregulated under all circumstances. Just as the Wnt-mediated stabilization of β-catenin requires accessory signaling cascades to promote nuclear localization (1, 2) , the Wnt-dependent stabilization of Slug and Snail must work in tandem with the broad spectrum of growth factors, cytokines, microenvironmental conditions, and mutations known to selectively or jointly increase Slug or Snail gene expression (1, 2, 14-16, 22, 40-42) . Regardless of the specific circumstances operative in vivo, our findings establish a heretofore unrecognized link between the canonical Wnt signal transduction cascade and the activation of Slug-dependent transcriptional programs.
Materials and Methods
Detailed protocols regarding cell culture, plasmid, siRNA and shRNA construction, pharmacologic treatment of cells, cell extract preparation, antibodies, immunoprecipitation, in vitro kinase assays, recombinant protein purification, chromatin immunoprecipitation analysis, invasion assays and patient sample immunohistochemistry are described in SI Text. The breast cancer patient cohort has been described previously (see SI Text). Use of human materials was approved by the University of Michigan Institutional Review Board with informed consent obtained from all patients.
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SI Materials and Methods
Cell Culture and Transfection. MDA-MB-231, MCF7, and 293T cell lines were purchased from ATCC and cultured in DMEM (Invitrogen) supplemented with 10% (vol/vol) FBS (Invitrogen). Cells were transiently transfected with mammalian expression constructs or siRNAs with Lipofectamine 2000 transfection reagent from Invitrogen. MCF7 cells stably expressing mock, Slug-WT, or -4A mutant were obtained from pooled, polyclonal populations selected with 1 mg/mL of G418 (Invitrogen) for 3 wk. MDA-MB-231 cells were infected with lentiviruses expressing Scr-shRNA, Slug-shRNA, LSD1-shRNA, Zeb1-shRNA, and Zeb2-shRNA or retroviruses expressing Scr-shRNA and Snail-shRNA. The infected cells were selected with 1 mg/mL of G418 or 0.5 μg/mL of puromycin for 2 wk and whole populations were harvested. Immortalized human mammary epithelial cells (provided by R. Weinberg, Massachusetts Institute of Technology, Cambridge, MA) were infected with lentiviruses expressing pLenti-lox, pLenti-lox-Snail-96A, or pLenti-lox-Slug-4A and sorted by FACS.
Reagents, Plasmids, and siRNAs. Recombinant Wnt3a and GSK3β were purchased from Millipore and New England Biolabs, respectively. MG132, cycloheximide (CHX), CHIR99021, SB16763, and BIO were obtained from Sigma. Human cDNA for Slug and Snail were amplified by PCR and subcloned into a pGEX-6P-1 vector (GST fusion vector; Amersham Biosciences) or p3XFLAG-CMV vector (Sigma). A full-length human BRCA1 promoter (from bp −1583 to +36) was amplified from 293T genomic DNA and subcloned into the pGL4-Luc vector (Promega). All mutants were generated using the QuikChange kit (Stratagene) as described previously (1) and all sequences were verified by DNA sequencing. HA-GSK3β, HA-ubiquitin, Myc-β-Trcp1, and a Slug-siRNA expression plasmid pLKO.1-Slug-shRNA were purchased from Addgene. Zeb1-siRNA expression plasmid pLKO.1-Zeb1-shRNA (clone ID TRCN0000017563) and Zeb2-siRNA expression plasmid pLKO.1-Zeb2-shRNA (clone ID TRCN0000013528) were purchased from Open Biosystems. Primers corresponding to human Snail (from ht 507-525) were cloned into the pSUPER vector to generate a pSUPER-Snail-shRNA expression plasmid. Stealth Select siRNAs targeting Snail and Slug were purchased from Invitrogen. BRCA1-siRNA, GSK3β-siRNA and β-Trcp1-siRNA were from Santa Cruz. pSUPER-FBXL14-shRNA was kindly provided by A. G. de Herreros (University of Pompeu Fabra, Barcelona, Spain).
Cell Extract Preparation. Cytoplasmic and nuclear fractions were prepared with the NE-PER extraction kit (Thermo) according to the manufacturer's instructions with slight modification. Briefly, cells were suspended in ice-cold CER I buffer plus protease inhibitor mixture (Thermo), vortexed for 15 s, and incubated on ice for 10 min. The lysates were vortexed for 5 s in the presence of CER II buffer, incubated on ice for 1 min, and vortexed for another 5 s, followed by centrifugation at 17,000 × g for 10 min. The supernatants were collected as cytoplasmic extracts, and the pellets were rinsed with ice-cold PBS and then resuspended in icecold NER buffer plus protease inhibitor mixture. The suspensions were incubated for 1 h with gentle agitation at 4°C. The lysates were centrifuged at 17,000 × g for 10 min and the supernatants were collected as nuclear extracts. To prepare the total cell lysates, cells were harvested and lysed in RIPA buffer (Sigma), followed by centrifugation at 17,000 × g for 20 min. The collected supernatants were used for GSK3β kinase analyses (see below).
Immunoblot, Immunoprecipitation, and in Vitro Kinase Assay. Cell lysates were incubated with anti-FLAG-M2 (Sigma) or anti-HA (Clontech) antibodies overnight at 4°C, followed by a 2-h incubation with protein G PLUS-agarose beads (Santa Cruz Biotechnology). Immunocomplexes were resolved by 4∼20% (vol/vol) SDS/PAGE and transferred to nitrocellulose membranes (Bio-Rad), followed by immunoblot analyses with the indicated antibodies. Immunoblot analyses were performed using the following antibodies against BRCA1 (Calbiochem), Snail, Slug, β-Trcp (all from Cell Signaling), FLAG-M2, β-actin (each from Sigma), β-catenin, E-cadherin, vimentin, GSK3β (all from BD Bioscience), HA (Clontech), or Myc (Santa Cruz Biotechnology) as indicated in the text. GSK3β kinase assays were performed as described previously with slight modification (2) . Briefly, nuclear extracts were incubated with anti-GSK3β antibody overnight at 4°C followed by a 2-h incubation with protein G PLUS-agarose beads (Santa Cruz Biotechnology). GSK3β was immunoprecipitated, and the immunocomplex was washed eight times with RIPA buffer (Sigma) and twice with incomplete kinase buffer containing 20 mM Tris (pH 7.5), 5 mM MgCl 2 , 1 mM DTT, and 250 μM ATP. The immunocomplex was then resuspended in 35 μL of complete kinase buffer containing 20 mM Tris (pH 7.5), 5 mM MgCl 2 , 1 mM DTT, 250 μM ATP, 5.0 μCi of [γ-32 P]ATP (PerkinElmer), and 150 μg/ mL of phosphoglycogen synthase peptide (Upstate). The samples were incubated at 30°C for 30 min, the reaction tubes were centrifuged for 1 min, and triplicate 10-μL aliquots of each sample were spotted on cellulose phosphate squares (Upstate). The filter paper was allowed to air-dry and then washed six times in 0.5% phosphoric acid for a total time of 1 h, followed by two 5-min washes in ethanol and acetone, respectively. The squares were then air-dried and the incorporated radioactivity quantified in a liquid scintillation counter (Beckman Coulter). In select cases, GSK3β kinase assays were performed in GSK3β kinase reaction buffer (New England Biolab) supplemented with 250 μM ATP and 10 μCi of [γ-32 P]ATP (3,000 Ci/mmol; PerkinElmer Life Sciences) for 30 min at 30°C in the presence of recombinant GSK3β (New England Biolab) and purified GST-Slug or GST-Snail proteins. Samples were then resolved by SDS/PAGE and subjected to autoradiography.
Quantitative RT-PCR. Total RNA was isolated with the RNeasy Mini Kit (QIAGEN) and 1 μg of reverse transcribed with random hexamers (SuperScript III cDNA Synthesis Kit; Invitrogen) according to the manufacturer's instructions. cDNA (5 ng) was amplified in a reaction volume of 15 μL using SYBR Green PCR mix (Applied Biosystems), and quantitative PCR (qPCR) was carried out using an ABI PRISM 7900HT (Applied Biosystems) sequence detection system. For any sample, the expression level, normalized to the housekeeping gene encoding GAPDH, was determined with the comparative threshold cycle (Ct) method. All primers are available upon request.
Recombinant Protein Purification. Recombinant protein purification was performed as described previously (1) . In brief, fulllength and various domains of Slug or Snail were subcloned into pGEX-6P-1 vector and expressed in Escherichia coli (BL21). Expression was induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside at 37°C for 3 h after the cell density had reached 0.5 A at 600 nm. Recombinant GST fusion proteins were affinity-purified by incubation with glutathione-agarose beads (Amersham) followed by extensive washes with STE buffer [10 mM Tris·HCl (pH 8.0), 1 mM EDTA, 150 mM NaCl] and elution with glutathione elution buffer (40 mM glutathione, 50 mM Tris·HCl, 10 mM DTT, 200 mM NaCl at pH 8.0).
Mass Spectrometry. Samples were prepared for liquid chromatography (LC)-MS/MS analysis by in-gel digestion. Briefly, samples were washed with 25mM ammonium bicarbonate followed by acetonitrile, reduced with 10 mM DTT at 60°C, followed by alkylation with 50 mM iodoacetamide at room temperature. Samples were digested with sequencing grade trypsin (Promega) at 37°C for 4 h. Reactions were quenched with formic acid and the supernatant was analyzed directly without further processing. Each gel digest was analyzed by nano LC-MS/MS with a NanoAcquity HPLC system (Waters) interfaced to a LTQ Orbitrap Velos (ThermoFisher). Peptides were loaded on a trapping column and eluted over a 75-μm analytical column at 300 nL/min; both columns were packed with Jupiter Proteo resin (Phenomenex). Data were acquired using collisioninduced dissociation (CID), the mass spectrometer was operated in data-dependent mode, MS was performed in the Orbitrap at 60,000 FWHM resolution, and MS/MS was performed in the Velos. Product ion data were searched against the combined forward and reverse IPI Human V3.75 protein database using the Mascot search engine v2.3.02 (Matrix Science) via Mascot Daemon v2.3.2. Mascot search result files (DAT) were parsed to the Scaffold program (Proteome Software) for visualization and validation. Identified phosphorylation sites were manually validated. A targeted electron transfer dissociation method was used for site validation for peptides producing poor CID spectra.
For characterizing Slug phosphorylation in vivo, 293T cells were transfected with FLAG-tagged Slug and samples were prepared as above. Data were acquired using either CID or higher energy collision-induced dissociation (HCD) methods. The mass spectrometer was operated in data-dependent mode; MS was performed in the Orbitrap at 60,000 FWHM resolution and MS/ MS was performed in the Velos (CID) or Orbitrap (HCD). The 15 most abundant ions were selected for MS/MS. Product ion data were searched against the combined forward and reverse IPI Human V3.75 human protein database using the Mascot search engine v2. 3 Chromatin Immunoprecipitation Analysis. For chromatin immunoprecipitation (IP) analysis, cells were crosslinked with 1% (vol/ vol) formaldehyde at room temperature, suspended in IP lysis buffer [50 mM Tris (pH 7.5), 1 mM EDTA, 1% (vol/vol) Nonidet P-40, 0.1% SDS, and protease inhibitor mixture] on ice, and the cell lysates were subjected to sonication. After centrifugation, the supernatants were incubated with FLAG-M2, H3K4-m2, H3K4-m3, H3K9-Ac antibodies or their corresponding normal IgGs overnight, followed by incubation with protein A or G-agarose beads (Santa Cruz Biotech Inc.) for 2 h at 4°C. Following extensive washes in IP lysis buffer, bound DNA-protein complexes were eluted and crosslinks were reversed following an overnight incubation at 65°C. Purified DNA was resuspended in TE buffer Immunohistochemical Staining. Two high-density tissue microarrays (TMAs) containing 113 primary invasive carcinomas of the breast developed and previously characterized by our group were used (4). The TMAs were subjected to immunohistochemistry to detect Snail, Slug, and BRCA1 proteins. Paraffin-embedded sections 5 μm thick were deparaffinized in xylene and rehydrated through graded alcohols to water. Heat-induced epitope retrieval was performed in the Decloaking Chamber (Biocare Medical) with Target Retrieval, pH 6.0 (DakoCytomation), for BRCA1 or Borg Decloaker (Biocare Medical) for Snail and Slug. Slides were incubated in 3% (gm/100ml) hydrogen peroxide for 5 min to quench endogenous peroxidases. Mouse monoclonal anti-BRCA1 (EMD Sciences) diluted 1:500 was incubated for 1 h at 37°C, and mouse monoclonal anti-Snail (Cell Signaling Technology) diluted 1:800 and rabbit monoclonal anti-Slug (Cell Signaling Technology) diluted 1:100 were incubated with TMAs for 1.5 h at room temperature. BRCA1, Snail, and Slug were detected with Mach 4 Universal HRP Polymer (Biocare Medical). HRP staining was visualized with the DAB + Kit (DakoCytomation). Negative control slides were run with either rabbit or mouse IgG. Slides were counterstained in hematoxylin, blued in running tap water, dehydrated through graded alcohols, cleared in xylene, and mounted with Permount. Expression of Snail and Slug were considered positive when nuclear expression was detected in the cancer cells or negative when Snail and/or Slug proteins were confined to the cytosol or undetected. BRCA1 was considered positive when the protein was detected in the nucleus of breast cancer cells and low/reduced when it was negative or only cytoplasmic, as previously reported (5) . Expression of Snail, Slug, and BRCA1 was evaluated as either low or high based on intensity of staining and percentage of staining cells, following guidelines established in the literature (6) . Pearson χ
2 test was performed to analyze the association between BRCA1 and Snail and/or Slug.
Statistical Analysis. All experiments were repeated three times or more. Results are expressed as mean ± SEM. Two-tailed Student t test, ANOVA test, and Pearson χ 2 test were used to compare intergroups and P < 0.05 was considered statistically significant. MDA-MB-231 cells were cotransfected with Scr-, Slug-, or Snail-siRNAs in combination with a BRCA1 promoter reporter construct and relative promoter activity was determined by luciferase assay. **P < 0.01. Interactions between Snail/Slug-E-cadherin promoter (E) or Snail/Slug-BRCA1 promoter (F) in MCF7 cells stably expressing Slug-WT, Slug-4A, Snail-WT, or Snail-96A expression vectors were assessed by chromatin IP/qPCR. **P < 0.01, treated vs. control. Fig. S5 . Snail/BRCA1 expression in human breast cancer tissues. The expression patterns of Snail, Slug, and BRCA1 in the subset of 57 triple-negative breast cancer samples were determined and summarized. Expression of Snail and Slug were considered positive when nuclear expression was detected in the cancer cells. BRCA1 was considered highly expressed when the protein was detected in the nucleus of breast cancer cells. Fig. S6 . Regulation of BRCA1 by Snail/Slug is Zeb1/Zeb2-independent. (A) MCF7 cells stably expressing mock, Slug-WT, or Slug-4A expression vectors were analyzed for Zeb1 and Zeb2 expression by qRT-PCR analysis. **P < 0.01. (B) MDA-MB-231 cells stably expressing Scr-, Slug-, or Snail-shRNAs were analyzed by qRT-PCR to monitor mRNA levels of Zeb1, Zeb2, Slug, and Snail. **P < 0.01. (C) MDA-MB-231 cells stably expressing Scr-, Zeb1-, Zeb2-, or Zeb1/Zeb2-shRNAs were analyzed by qRT-PCR to monitor mRNA levels of Zeb1, Zeb2, BRCA1, and BRCA2. **P < 0.01. Fig. S7 . Snail/Slug controls DNA damage responses in immortalized human mammary epithelial cells (hMLECs). hMLECs stably expressing mock, Slug-4A or Snail-96A expression vectors were analyzed for Zeb1, Zeb2, VIM, FN, CDH1 and OCLN levels by qRT-PCR (A) and immunofluorescent staining with anti-vimentin antibody or phase contrast microscopy (B). hMLECs stably expressing mock, Slug-4A, or Snail-96A expression vectors were treated with 25 μM etoposide for 6 h (1) and subjected to Western blot (C), qRT-PCR for BRCA1 and BRCA2 expression levels (D) and immunofluorescent staining with anti-γ-H2AX antibody (E). **P < 0.01.
